Atrial Fibrillation – An Orchestra of Classic and Modern Risk Factors

1. Benjamin EJ, Levy D, Vaziri SM, D’Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994;271:840-844.10.1001/jama.1994.03510350050036Search in Google Scholar

2. Brandes A, Smit MD, Nguyen BO, Rienstra M, Van Gelder IC. Risk factor management in atrial fibrillation. Arrhythm Electrophysiol Rev. 2018;7:118-127.10.15420/aer.2018.18.2Search in Google Scholar

3. Lau DH, Mackenzie L, Kelly DJ, et al. Short-term hypertension is associated with the development of atrial fibrillation substrate: a study in an ovine hypertensive model. Heart Rhythm. 2010;7:396-404.10.1016/j.hrthm.2009.11.031Search in Google Scholar

4. Goette A, Staack T, Rocken C, et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol. 2000;35:1669-1677.10.1016/S0735-1097(00)00611-2Search in Google Scholar

5. Goette A, Arndt M, Rocken C, et al. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans. Circulation. 2000;101:2678-2681.10.1161/01.CIR.101.23.2678Search in Google Scholar

6. Okazaki H, Minamino T, Tsukamoto O, et al. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res. 2006;29:277-284.10.1291/hypres.29.27716778335Search in Google Scholar

7. Scridon A, Gallet C, Arisha MM, et al. Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol. 2012;303:H386-H392.10.1152/ajpheart.00004.201222661510Search in Google Scholar

8. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study. Circulation. 2003;107:2920-2925.10.1161/01.CIR.0000072767.89944.6E12771006Search in Google Scholar

9. Lee KW, Everett TH 4th, Rahmutula D, et al. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure. Circulation. 2006;114:1703-1712.10.1161/CIRCULATIONAHA.106.624320212910317030685Search in Google Scholar

10. Yeh YH, Wakili R, Qi XY, et al. Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ Arrhythm Electrophysiol. 2008;1:93-102.10.1161/CIRCEP.107.75478819808399Search in Google Scholar

11. Li D, Melnyk P, Feng J, et al. Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation. 2000;101:2631-2638.10.1161/01.CIR.101.22.2631Search in Google Scholar

12. Cardin S, Li D, Thorin-Trescases N, Leung TK, Thorin E, Nattel S. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and independent pathways. Cardiovasc Res. 2003;60:315-325.10.1016/j.cardiores.2003.08.014Search in Google Scholar

13. Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105:2753-2759.10.1161/01.CIR.0000018443.44005.D8Search in Google Scholar

14. Nakashima H, Kumagai K, Urata H, Gondo N, Ideishi M, Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation. 2000; 101:2612-2617.10.1161/01.CIR.101.22.2612Search in Google Scholar

15. Scridon A, Dobreanu D, Chevalier P, Șerban RC. Inflammation, a link between obesity and atrial fibrillation. Inflamm Res. 2015;64:383-393.10.1007/s00011-015-0827-8Search in Google Scholar

16. Kannel WB, Abbott RD, Savage DD, McNamara PM. Coronary heart disease and atrial fibrillation: the Framingham Study. Am Heart J. 1983;106:389–396.10.1016/0002-8703(83)90208-9Search in Google Scholar

17. Lammers WJ, Kirchhof C, Bonke FI, Allessie MA. Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol. 1992;262:H47-H55.10.1152/ajpheart.1992.262.1.H471733321Search in Google Scholar

18. Sinno H, Derakhchan K, Libersan D, Merhi Y, Leung TK, Nattel S. Atrial ischemia promotes atrial fibrillation in dogs. Circulation. 2003;107:1930-1936.10.1161/01.CIR.0000058743.15215.0312668526Search in Google Scholar

19. Şerban RC, Scridon A. Data Linking diabetes mellitus and atrial fibrillation-how strong is the evidence? From epidemiology and pathophysiology to therapeutic implications. Can J Cardiol. 2018;34:1492-1502.10.1016/j.cjca.2018.08.01830404752Search in Google Scholar

20. Rutter MK, Parise H, Benjamin EJ, et al. Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study. Circulation. 2003;107:448-454.10.1161/01.CIR.0000045671.62860.9812551870Search in Google Scholar

21. Kato T, Yamashita T, Sekiguchi A, et al. What are arrhythmogenic substrates in diabetic rat atria? J Cardiovasc Electrophysiol. 2006;17:890-894.10.1111/j.1540-8167.2006.00528.xSearch in Google Scholar

22. Chao TF, Suenari K, Chang SL, et al. Atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation associated with diabetes mellitus or impaired fasting glucose. Am J Cardiol. 2010;106:1615-1620.10.1016/j.amjcard.2010.07.03821094363Search in Google Scholar

23. Otake H, Suzuki H, Honda T, Maruyama Y. Influences of autonomic nervous system on atrial arrhythmogenic substrates and the incidence of atrial fibrillation in diabetic heart. Int Heart J. 2009;50:627-641.10.1536/ihj.50.62719809211Search in Google Scholar

24. Wang TJ, Parise H, Levy D, et al. Obesity and the risk of new-onset atrial fibrillation. JAMA. 2004;292:2471-2477.10.1001/jama.292.20.247115562125Search in Google Scholar

25. Pathak RK, Middeldorp ME, Meredith M, et al. Long-term effect of goal-directed weight management in an atrial fibrillation cohort: A long-term follow-up study (LEGACY). J Am Coll Cardiol. 2015;65:2159-2169.10.1016/j.jacc.2015.03.00225792361Search in Google Scholar

26. Abed HS, Samuel CS, Lau DH, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10:90-100.10.1016/j.hrthm.2012.08.04323063864Search in Google Scholar

27. Munger TM, Dong YX, Masaki M, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60:851-860.10.1016/j.jacc.2012.03.04222726633Search in Google Scholar

28. Lin YK, Chen YC, Chen JH, Chen SA, Chen YJ. Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation. Basic Res Cardiol. 2012;107:293-303.10.1007/s00395-012-0293-122886089Search in Google Scholar

29. Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep disordered breathing: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2006;173:910-916.10.1164/rccm.200509-1442OC266290916424443Search in Google Scholar

30. Orban M, Bruce CJ, Pressman GS, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102:1557-1561.10.1016/j.amjcard.2008.07.050263821019026314Search in Google Scholar

31. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96:1897-1904.10.1172/JCI1182351858267560081Search in Google Scholar

32. Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration. 2003;70:665-671.10.1159/00007521814732803Search in Google Scholar

33. Stevenson IH, Roberts-Thomson KC, Kistler PM, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7:1263-1270.10.1016/j.hrthm.2010.03.02020338265Search in Google Scholar

34. Linz D, Schotten U, Neuberger HR, Böhm M, Wirth K. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8:1436-1443.10.1016/j.hrthm.2011.03.05321457790Search in Google Scholar

35. Qureshi WT, Alirhayim Z, Blaha MJ, et al. Cardiorespiratory fitness and risk of incident atrial fibrillation: results from the Henry Ford Exercise Testing (FIT) Project. Circulation. 2015;131:1827-1834.10.1161/CIRCULATIONAHA.114.01483325904645Search in Google Scholar

36. Abdulla J, Nielsen JR. Is the risk of atrial fibrillation higher in athletes than in the general population? A systematic review and meta-analysis. Europace. 2009;11:1156-1159.10.1093/europace/eup19719633305Search in Google Scholar

37. Thorp AA, Owen N, Neuhaus M, Dunstan DW. Sedentary behaviors and subsequent health outcomes in adults a systematic review of longitudinal studies, 1996-2011. Am J Prev Med. 2011;41:207-215.10.1016/j.amepre.2011.05.00421767729Search in Google Scholar

38. Allison MA, Jensky NE, Marshall SJ, Bertoni AG, Cushman M. Sedentary behavior and adiposity-associated inflammation: the Multi-Ethnic Study of Atherosclerosis. Am J Prev Med. 2012;42:8-13.10.1016/j.amepre.2011.09.023324467622176840Search in Google Scholar

39. Mueller PJ. Exercise training and sympathetic nervous system activity: evidence for physical activity dependent neural plasticity. Clin Exp Pharmacol Physiol. 2007;34:377-384.10.1111/j.1440-1681.2007.04590.x17324153Search in Google Scholar

40. Lindsay MM, Dunn FG. Biochemical evidence of myocardial fibrosis in veteran endurance athletes. Br J Sports Med. 2007;41:447-452.10.1136/bjsm.2006.031534246535817311809Search in Google Scholar

41. Guasch E, Benito B, Qi X, et al. Atrial fibrillation promotion by endurance exercise: demonstration and mechanistic exploration in an animal model. J Am Coll Cardiol. 2013;62:68-77.10.1016/j.jacc.2013.01.09123583240Search in Google Scholar

42. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace. 2009;11:11-17.10.1093/europace/eun289263865518988654Search in Google Scholar

43. Shang W, Li L, Huang S, et al. Chronic kidney disease and the risk of new-onset atrial fibrillation: a meta-analysis of prospective cohort studies. PLoS One. 2016;11:e0155581.10.1371/journal.pone.0155581486673127175779Search in Google Scholar

44. Fukunaga N, Takahashi N, Hagiwara S, et al. Establishment of a model of atrial fibrillation associated with chronic kidney disease in rats and the role of oxidative stress. Heart Rhythm. 9:2023-2031.10.1016/j.hrthm.2012.08.01922906534Search in Google Scholar

45. Beretta-Piccoli C, Weidmann P, Schiffl H, Cottier C, Reubi FC. Enhanced cardiovascular pressor reactivity to norepinephrine in mild renal parenchymal disease. Kidney Int. 1982;22:297-303.10.1038/ki.1982.1697176332Search in Google Scholar

46. Konecny T, Park JY, Somers KR, et al. Relation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmias. Am J Cardiol. 2014;114:272-277.10.1016/j.amjcard.2014.04.03024878126Search in Google Scholar

47. Hubatsch M, Kikeli P, Preg Z, et al. Risk factor for complex chronic comorbidities, a retrospective case-control study. Acta Medica Marisiensis. 2011;57:209-213.Search in Google Scholar

48. Johnson LS, Juhlin T, Engström G, Nilsson PM. Reduced forced expiratory volume is associated with increased incidence of atrial fibrillation: the Malmo Preventive Project. Europace. 2014;16:182-188.10.1093/europace/eut25523960091Search in Google Scholar

49. Acar G, Kahraman H, Akkoyun M, et al. Evaluation of atrial electromechanical delay and its relationship to inflammation and oxidative stress in patients with chronic obstructive pulmonary disease. Echocardiography. 2014;31:579-585.10.1111/echo.1244224372655Search in Google Scholar

50. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59:574-580.10.1136/thx.2003.019588174707015223864Search in Google Scholar

51. Heeringa J, Kors JA, Hofman A, van Rooij FJ, Witteman JC. Cigarette smoking and risk of atrial fibrillation: the Rotterdam Study. Am Heart J. 2008;156:1163-1169.10.1016/j.ahj.2008.08.00319033014Search in Google Scholar

52. Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: An update. J Am Coll Cardiol. 2004;43:1731-1737.10.1016/j.jacc.2003.12.04715145091Search in Google Scholar

53. Shan H, Zhang Y, Lu Y, et al. Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines. Cardiovasc Res. 2009;83:465-472.10.1093/cvr/cvp130Search in Google Scholar

54. Laustiola KE, Kotamaki M, Lassila R, Kallioniemi OP, Manninen V. Cigarette smoking alters sympathoadrenal regulation by decreasing the density of beta 2-adrenoceptors. A study of monitored smoking cessation. J Cardiovasc Pharmacol. 1991;17:923-928.10.1097/00005344-199106000-00010Search in Google Scholar

55. Wang H, Yang B, Zhang L, Xu D, Wang Z. Direct block of inward rectifier potassium channels by nicotine. Toxicol Appl Pharmacol. 2000;164:97-101.10.1006/taap.2000.8896Search in Google Scholar

56. Gallagher C, Hendriks JML, Elliott AD, et al. Alcohol and incident atrial fibrillation – A systematic review and meta-analysis. Int J Cardiol. 2017;246:46-52.10.1016/j.ijcard.2017.05.133Search in Google Scholar

57. Gallardo-Carpentier A, Aileru AA, Carpentier RG. Arrhythmogenic and antiarrhythmic actions of substances of abuse: effects on triggered activity. J Electrocardiol. 1997;30:137-142.10.1016/S0022-0736(97)80022-2Search in Google Scholar

58. Qiao Y, Shi R, Hou B, et al. Impact of alcohol consumption on substrate remodeling and ablation outcome of paroxysmal atrial fibrillation. J Am Heart Assoc. 2015;4:e002349.10.1161/JAHA.115.002349Search in Google Scholar

59. Laszlo R, Eick C, Schwiebert M, et al. Alcohol-induced electrical remodeling: effects of sustained short-term ethanol infusion on ion currents in rabbit atrium. Alcohol Clin Exp Res. 2009;33:1697-1703.10.1111/j.1530-0277.2009.01006.xSearch in Google Scholar

60. Gould L, Reddy CV, Becker W, Oh KC, Kim SG. Electrophysiologic properties of alcohol in man. J Electrocardiol. 1978;11:219-226.10.1016/S0022-0736(78)80120-4Search in Google Scholar

61. Cardy MA, Donnerstein RL, Kelly LF, Bittner NH, Palombo GM, Goldberg SJ. Acute effects of ethanol ingestion on signal-averaged electrocardiograms. Am J Cardiol. 1996;77:1356-1357.10.1016/S0002-9149(96)00205-6Search in Google Scholar

62. Süfke S, Fiedler S, Djonlagiç H, Kibbel T. Continuous analysis of heart rate variability for examination of cardiac autonomic nervous system after alcohol intoxication. Med Klin (Munich.) 2009;104:511-519.10.1007/s00063-009-1110-ySearch in Google Scholar

63. Shao Q, Liu T, Korantzopoulos P, Zhang Z, Zhao J, Li G. Association between air pollution and development of atrial fibrillation: A meta-analysis of observational studies. Heart Lung. 2016;45:557-562.10.1016/j.hrtlng.2016.08.00127590407Search in Google Scholar

64. Peters A, Fröhlich M, Döring A, et al. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J. 2001;22:1198-1204.10.1053/euhj.2000.248311440492Search in Google Scholar

65. Schwartz J, Litonjua A, Suh H, et al. Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax. 2005;60:455-461.10.1136/thx.2004.024836174741915923244Search in Google Scholar

66. Liao D, Shaffer ML, He F, et al. Fine particulate air pollution is associated with higher vulnerability to atrial fibrillation-the APACR study. J Toxicol Environ Health A. 2011;74:693-705.10.1080/15287394.2011.556056308284921480044Search in Google Scholar

67. Rienstra M, Hobbelt AH, Alings M, et al. Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial. Eur Heart J. 2018;39:2987-2996.10.1093/eurheartj/ehx73929401239Search in Google Scholar